4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-24-008886
CEO sold 20,272 shares at $29.84 ($604,876)
- CEO acquired 66,577 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Shah Gaurav · CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-16 | Sale : show line 1 in the form | −20,272 | $29.84 | $604,876 | 554,762 | D |
| 2024-02-16 | Grant or award : show line 2 in the form | +66,577 | 621,339 | D | ||
| Open-market sales · 20,272 sh · avg $29.84 · $604,876 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-16 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +196,336 | 196,336 | D |
Loading xslF345X05/form4.xml…